A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.

SARS-CoV-2 epidemics raises a considerable issue of public health at the planetary scale. There is a pressing urgency to find treatments based upon currently available scientific knowledge. Therefore, we tentatively propose a hypothesis which hopefully might ultimately help save lives. Based on the current scientific literature and on new epidemiological data which reveal that current smoking status appears to be a protective factor against the infection by SARS-CoV-2 [1], we hypothesize that the nicotinic acetylcholine receptor (nAChR) plays a key role in the pathophysiology of Covid-19 infection and might represent a target for the prevention and control of Covid-19 infection.

• Publication year

  2020

• Venue

  Comptes rendus. Biologies

• Publication date

  2020-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.32388/fxgqsb.2PMID 32720486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial Compilation X

  2021cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

  2020cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

  2020cited by this paper
• Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

  2020cited by this paper
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

  2020cited by this paper
• Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

  2020cited by this paper
• Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

  2020cited by this paper
• The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

  2020cited by this paper
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

  2020cited by this paper
• Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms

  2020cited by this paper
• Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China

  2020cited by this paper
• Clinical characteristics of 2019 novel coronavirus infection in China

  2020cited by this paper
• Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019

  2020cited by this paper
• Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

  2020cited by this paper
• Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor

  2020cited by this paper
• Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)

  2020cited by this paper
• Clinical features and treatment of COVID‐19 patients in northeast Chongqing

  2020cited by this paper
• Clinical and immunologic features in severe and moderate Coronavirus Disease 2019.

  2020cited by this paper
• Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19

  2020cited by this paper
• Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

  2020cited by this paper
• COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome

  2020cited by this paper
• Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?

  2020cited by this paper
• The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

  2020cited by this paper
• The protein expression profile of ACE2 in human tissues

  2020cited by this paper
• What Is COVID-19?

  2020cited by this paper
• Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis

  2020cited by this paper
• Epidemiological, Clinical Characteristics and Outcome of Medical Staff Infected with COVID-19 in Wuhan, China: A Retrospective Case Series Analysis

  2020cited by this paper
• Low rate of daily smokers in patients with symptomatic COVID-19

  2020cited by this paper
• What is C++?

  2020influential reference
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Nicotinic-nAChR signaling mediates drug resistance in lung cancer

  2020cited by this paper
• [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control].

  2020cited by this paper
• Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody.

  2020cited by this paper
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  2020cited by this paper
• Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

  2020cited by this paper
• Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

  2020cited by this paper
• Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons

  2018cited by this paper
• Nicotine and the renin-angiotensin system.

  2018cited by this paper
• Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNS

  2017cited by this paper
• Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis

  2015cited by this paper
• The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation.

  2015cited by this paper
• H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep–wake regulatory neurons in mice

  2015cited by this paper
• The vagus nerve and the inflammatory reflex—linking immunity and metabolism

  2012cited by this paper
• Structure and pharmacology of pentameric receptor channels: from bacteria to brain.

  2012cited by this paper
• Microbes' roadmap to neurons

  2011cited by this paper
• A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Initially Mimicking Cutaneous Lupus Erythematosus

  2010cited by this paper
• Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function

  2010cited by this paper
• Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

  2010cited by this paper
• {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation.

  2009cited by this paper
• The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.

  2006cited by this paper
• Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants

  2005influential reference
• The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis.

  2005cited by this paper
• Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts

  2004cited by this paper
• Neuronal nicotinic receptors: from structure to pathology.

  2004cited by this paper
• Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

  2003cited by this paper
• Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

  2002cited by this paper
• Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

  1998cited by this paper
• Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor

  1998cited by this paper
• Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors.

  1998cited by this paper
• Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells.

  1997cited by this paper
• Viruses and Behavioural Changes: A Review of Clinical and Experimental Findings

  1993influential reference
• Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor

  1987cited by this paper
• Is the acetylcholine receptor a rabies virus receptor?

  1982cited by this paper
• Use of a snake venom toxin to characterize the cholinergic receptor protein.

  1970cited by this paper
• Modes of actions of purified toxins from elapid venoms on neuromuscular transmission.

  1966cited by this paper
• Modes of actions of purified toxins from elapid venoms on neuromuscular transmission.

  1966cited by this paper

• Long COVID – a critical disruption of cholinergic neurotransmission?

  2025influential citation
• National and sub-national sero-epidemiology of immunoglobulin G against SARS-CoV-2 in Iran in 2021

  2025cites this paper
• A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats

  2025cites this paper
• Remission of myasthenia gravis following infection with SARS-CoV-2

  2025cites this paper
• Cone Snail Broad-Transcriptomics Elucidate the Evolutionary Diversification and Anti-Microbial Potential of Conopeptides

  2025cites this paper
• A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2

  2025cites this paper
• Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies.

  2025influential citation
• Measures that could prevent the next viral pandemic

  2025cites this paper
• The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury

  2025cites this paper
• HSV1 glycoprotein D utilizes an LY6-like binding domain to inhibit alpha7 nicotinic receptors

  2025cites this paper
• Lessons learned from the COVID-19 pandemic: the intranasal administration as a route for treatment – a patent review

  2025cites this paper
• Assessment of smoking exposure by urine cotinine levels in severe COVID-19 patients: a case-control study

  2025cites this paper
• What Is the Real Impact of Smoking on Diseases Alleged to Benefit from It?

  2025cites this paper
• Insights into the pathogenic mechanisms associated with the SARS-CoV-2 spike protein.

  2025cites this paper
• Spectrum of COVID-19 cases in Arkhangelsk, Northwest Russia: Findings from a population-based study linking serosurvey, registry data, and self-reports of symptoms

  2024cites this paper
• Changes in Smoking Behavior in the COVID-19 Pandemic: A Single Center Study in Family Practice

  2024cites this paper
• THE ROLE OF α7 NICOTINIC ACETYLCHOLINE RECEPTORS IN POST-ACUTE SEQUELAE OF COVID-19.

  2024cites this paper
• E-cigarette Use and Severe Coronavirus Disease 2019 (COVID-19) Outcomes: A Meta-Analysis

  2024cites this paper
• Exploring the Impact of COVID-19 on Ulcerative Colitis Patients: A Lifestyle Perspective

  2024cites this paper
• Activity of the Tobacco Industry in Research and Scientific Literature

  2024cites this paper
• The Effects of Nicotine and Cannabinoids on Cytokines.

  2024cites this paper
• Predicting susceptibility to COVID-19 infection in patients on maintenance hemodialysis by cross-coupling soluble ACE2 concentration with lymphocyte count: an algorithmic approach

  2024cites this paper
• An observational study of post-vaccination symptoms of inactivated virus vaccine versus mRNA COVID-19 vaccine

  2024cites this paper
• Clinical manifestations and treatment outcomes among hospitalised COVID-19 patients in tertiary hospitals in Tanzania, 2021–2022: a retrospective cohort study

  2024cites this paper
• The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression.

  2024cites this paper
• Improvements in mental health associated with increased electronic communication and deterioration in physical health in adults aged 50+ during the COVID-19 pandemic

  2024cites this paper
• In Vitro Screening of an In-House Library of Structurally Distinct Chemotypes Towards the Identification of Novel SARS-CoV-2 Inhibitors

  2024cites this paper
• α7 Nicotinic Receptor Activation Mitigates Herpes Simplex Virus Type 1 Infection in Microglia Cells.

  2024cites this paper
• Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology

  2024cites this paper
• Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

  2024cites this paper
• Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?

  2023influential citation
• Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation

  2023cites this paper
• Synergistic Detrimental Effects of Cigarette Smoke, Alcohol, and SARS-CoV-2 in COPD Bronchial Epithelial Cells

  2023cites this paper
• Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

  2023cites this paper
• SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors

  2023cites this paper
• ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA

  2023cites this paper
• New insights into how popular electronic cigarette aerosols and aerosol constituents affect SARS-CoV-2 infection of human bronchial epithelial cells

  2023cites this paper
• Hydroxyurea interaction with α7 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19.

  2023cites this paper
• Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?

  2023cites this paper
• α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain

  2023cites this paper
• New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects

  2023cites this paper
• Smoking as a Risk or Protective Factor in Developing and Severity of COVID-19?

  2023cites this paper
• Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy

  2023cites this paper
• Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin

  2023cites this paper
• Clinical manifestations and mortality among hospitalized COVID-19 patients in Tanzania, 2021-2022.

  2023influential citation
• Substances of abuse and their effect on SAR-CoV-2 pathogenesis

  2023cites this paper
• SARS-CoV-2 Spike Protein Downregulates Cell Surface α7nAChR through a Helical Motif in the Spike Neck

  2023cites this paper
• Recent advances in cholinergic mechanisms: A preface for the ISCM2022 special issue

  2023cites this paper
• Unanswered questions in the regulation and function of the duplicated α7 nicotinic receptor gene CHRFAM7A.

  2023cites this paper
• Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: role of α7 nicotinic acetylcholine receptors.

  2023cites this paper
• Carbon dioxide and MAPK signalling: towards therapy for inflammation

  2023cites this paper
• COVID‐19 and tobacco products use among US adults, 2021 National Health Interview Survey

  2023cites this paper
• Does misclassification of former tobacco smokers explain the ‘smoker’s paradox’ in the risk of COVID-19? Insights from the Stockholm Public Health Cohort

  2023cites this paper
• Changes in cigarette consumption and intention to quit in response to the COVID-19 pandemic in China

  2023cites this paper
• Content Analysis of YouTube Videos Related to E-cigarettes and COVID-19

  2023cites this paper
• The Role of the Acetylcholine System in Common Respiratory Diseases and COVID-19

  2023cites this paper
• Potential value of neuroimmunotherapy for COVID-19: efficacies and mechanisms of vagus nerve stimulation, electroacupuncture, and cholinergic drugs

  2023cites this paper
• The diplomacy of tobacco smoke with COVID-19: A commentary

  2023cites this paper
• The Association Between Tobacco Use and Risk of COVID-19 Infection and Clinical Outcomes in Sweden: A Population-Based Study

  2023cites this paper
• Immunization with 674–685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice

  2022cites this paper
• Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity

  2022cites this paper
• A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor

  2022cites this paper
• Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

  2022cites this paper
• The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?

  2022cites this paper
• E-cigarettes and youth: an unresolved Public Health concern

  2022influential citation
• Association between smoking and COVID-19 severity: A multicentre retrospective observational study

  2022cites this paper
• Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study

  2022influential citation
• Inflammatory reflex disruption in COVID‐19

  2022cites this paper
• A Model for the Lifespan Loss Due to a Viral Disease: Example of the COVID-19 Outbreak

  2022cites this paper
• In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds

  2022cites this paper
• The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders

  2022cites this paper
• Dynamics, outcomes and prerequisites of the first SARS-CoV-2 superspreading event in Germany in February 2020: a cross-sectional epidemiological study

  2022cites this paper
• Charming e-cigarette users with distorted science: a survey examining social media platform use, nicotine-related misinformation and attitudes towards the tobacco industry

  2022cites this paper
• Communication intervention to improve perceived threat of smoking-related COVID-19 and intentions to quit smoking during the COVID-19 pandemic in Thailand

  2022cites this paper
• Association between smoking, e-cigarette use and severe COVID-19: a cohort study

  2022cites this paper
• Evaluation of post-COVID health status using the EuroQol-5D-5L scale

  2022cites this paper
• Omicron and Alpha P680H block SARS-CoV2 spike protein from accessing cholinergic inflammatory pathway via α9-nAChR mitigating the risk of MIS-C

  2022cites this paper
• Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China

  2022cites this paper
• Changes in Cigarette Smoking and Vaping in Response to the COVID-19 Pandemic in the UK: Findings from Baseline and 12-Month Follow up of HEBECO Study

  2022cites this paper
• COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis

  2022cites this paper
• A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody

  2022cites this paper
• Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study

  2022cites this paper
• Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research

  2022cites this paper
• Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics

  2022influential citation
• Impact of Smoking on COVID-19 Symptoms in Non-Vaccinated Patients: A Matched Observational Study from Qatar

  2022cites this paper
• Pathophysiological Basis of COVID-19

  2022cites this paper
• Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile

  2022cites this paper
• COVID-19 and Current Smoking: Worse Outcome from a Surveillance Analysis

  2022influential citation
• COVID-19’s pandemic effects on smokers: A minireview

  2022cites this paper
• Omicron SARS-CoV-2 Spike-1 Protein’s Decreased Binding Affinity to α7nAChr: Implications for Autonomic Dysregulation of the Parasympathetic Nervous System and the Cholinergic Anti-Inflammatory Pathway—An In Silico Analysis

  2022influential citation
• Universal nature of cholinergic regulation demonstrated with nicotinic acetylcholine receptors.

  2022cites this paper
• Barriers Against and Motivations for Quitting Smoking during the COVID-19 Health Crisis: Results of a Qualitative Study in France

  2022cites this paper
• Does Vaping Increase the Likelihood of SARS-CoV-2 Infection? Paradoxically Yes and No

  2022cites this paper
• An experimental test of the nicotinic hypothesis of COVID-19

  2022cites this paper
• Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity

  2022cites this paper
• Nicotine in Combination with SARS-CoV-2 Affects Cells Viability, Inflammatory Response and Ultrastructural Integrity

  2022cites this paper
• Nicotine has no significant cytoprotective activity against SARS-CoV-2 infection

  2022cites this paper
• New Insights into How JUUL™ Electronic Cigarette Aerosols and Aerosol Constituents Affect SARS-CoV-2 Infection of Human Bronchial Epithelial Cells

  2022cites this paper
• Smoking, nicotine, and COVID-19

  2022cites this paper
• Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research

  2022cites this paper